Status
Terminated
Drug Enforcement D-0102-2024
Presence of Particulate Matter: identified as glass.
Classification
Class I
Report Date
November 15, 2023
Termination Date
February 14, 2025
Product Information
- Product description
- 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11
- Product quantity
- 3,200 vials
- Reason for recall
- Presence of Particulate Matter: identified as glass.
- Recall initiation reason
- —
- Initial firm notification
- Letter
- Distribution pattern
- Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.
Location & Firm
- Recalling firm
- Pfizer Inc.
- Address
-
235 East 42nd Street
United States - Voluntary / Mandated
- Voluntary: Firm initiated
- Status date
- —
Codes & Dates
- Recall number
- D-0102-2024
- Event ID
- 93124
- Recall initiation date
- October 2, 2023
- Center classification date
- November 9, 2023
- Code info
- Lot#: GH6567, Exp. 7/1/2024
- More code info
- —